
Agappe to Begin Manufacturing of US FDA-Approved Plasma Markers for Alzheimer's Disease Detection in India
COCHIN, KERALA, INDIA, June 20, 2025 /EINPresswire.com/ -- Agappe Diagnostics Ltd is poised to pioneer a transformative chapter in Alzheimer’s diagnostics by commencing manufacturing of US FDA-approved plasma biomarkers—Amyloid Beta 1-42 and …